Clinical Implications of the Recent Dose-Ranging Studies of Adalimumab

G&H How was adalimumab dosing determined for the treatment of Crohn’s disease and ulcerative colitis? BF Currently, standard induction dosing is 160 mg initially, followed […]

Gastro-Hep News

European Commission Approves Fifth Adalimumab Biosimilar On September 20, 2018, the European Commission (EC) granted marketing authorization for the adalimumab (Humira, AbbVie) biosimilar Hulio (Mylan and […]